Skip to main content

Find Clinical Trials

Home
Conditions
Sexually Transmitted Diseases

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,120 public trials 374 recruiting studies

Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

NCT00225303

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

NCT00964327

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00269945

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy

NCT00270283

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

NCT00141284

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations: Pfizer Investigational Site Bakersfield, California, United States

Pfizer Investigational Site Miami, Florida, United States

Pfizer Investigational Site Shreveport, Louisiana, United States

Pfizer Investigational Site Dallas, Texas, United States

View Trial Details

Completed

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

NCT00085943

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Sacramento, California, United States

View all 119 locations

View Trial Details

Completed

EuroSIDA As An External Comparator To MOTIVATE Trials

NCT01329783

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details

Completed

Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue

NCT00775294

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: UNC Hospitals CTRC Chapel Hill, North Carolina, United States

View Trial Details